Please login to the form below

Not currently logged in
Email:
Password:

UK knows ‘almost nothing’ about pancreatic cancer

Celgene-sponsored survey shows 64% of people know little about the disease

UK flag 

Nearly two thirds of the UK population is lacking in awareness of pancreatic cancer, according to a new survey sponsored by Celgene.

According to data collected from 7,000 adults in Europe and the US, 64% of people in the UK say they know 'almost nothing' about the disease despite it being the fifth most common cause of death among cancers in the UK.

In response, Celgene said it would be begin a working partnership with pancreatic cancer organisations, such as Pancreatic Cancer UK and Pancreatic Cancer Action, to raise the level of education and awareness about the disease and emphasise the need for change in attitude.

This includes supporting World Pancreatic Cancer Day, which took place last week on November 13.

Markus Renschler, senior VP and global head of hematology and oncology medical affairs for Celgene, said: “Putting a dent in the rather grim pancreatic cancer statistics will be challenging, but with the appropriate treatment and the more than 170 global clinical trials evaluating investigational treatments in approximately 35,000 patients we believe outcomes will be improved for patients.”

Awareness was also lacking in other countries surveyed across Europe and the US. Respondents in Spain knew the least about pancreatic cancer, with 26% admitting to knowing almost nothing.

Across all countries, 61% of respondents ranked supporting ways to increase screening and earlier diagnosis as being among the most important goals in terms of raising awareness, followed by a call for more research to prevent pancreatic cancer (53%).

Ali Stunt, founder and CEO of Pancreatic Cancer Action: “Throughout the world, this type of cancer has been persistently underfunded and has languished in the 'too-hard-to-deal-with' category for far too long. This is reflected in the dire survival rates. More investment into both research and treatment is required to make the long overdue improvements in outcomes for patients.”

Article by
Kirstie Pickering

17th November 2014

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Origins Insights

Our goal is to identify and embed transformational patient insights as a fundamental part of the drug development process. As...

Latest intelligence

The doctor will text you now: Why healthcare providers cannot underestimate the importance of communicating change
Healthcare communication needs to switch from ‘transmit’ to ‘receive’, listening to what patients need and embracing the plethora of communication tools wholeheartedly....
How to innovate and influence people in times of misinformation
The pandemic has shown that public trust in promising new medical technologies is far from a given. Senior Writer Tom Vandyck at StoneArch, a member of Fishawack delves into the...
Could femtech be the answer to the gender health gap?
Here, we discuss the phenomenon of femtech, an industry that puts women’s experiences of lifestyle and health front and centre. We highlight some of the major players in the industry,...